Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-02 Sale | 2023-08-04 4:47 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 509 | $34.88 | $17,751 | 52,440 (Direct) | View |
2023-06-06 Sale | 2023-06-07 9:36 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 3,636 | $38.42 | $139,680 | 41,356 (Direct) | View |
2022-08-03 Sale | 2022-08-05 4:06 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 476 | $55.7 | $26,513 | 44,992 (Direct) | View |
2022-06-06 Sale | 2022-06-08 7:48 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 17,546 | $61.39 | $1,077,135 | 69,860 (Direct) | View |
2021-06-04 Sale | 2021-06-08 4:20 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 2,276 | $61.04 | $138,920 | 24,035 (Direct) | View |
2021-03-31 Sale | 2021-04-02 6:33 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 22,224 | $70.61 | $1,569,195 | 32,561 (Direct) | View |
2020-11-13 Sale | 2020-11-17 5:30 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 5,000 | $62 | $310,000 | 34,785 (Direct) | View |
2020-03-11 Purchase | 2020-03-12 7:18 pm | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 2,500 | $36.5 | $91,250 | 25,237 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-14 Option Award | 2023-06-16 5:45 pm | N/A 2033-06-14 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 38,450 | $0 | 79,806 (Direct) | View |
2022-06-06 Exercise | 2022-06-08 7:48 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 6,250 | $34.38 | 69,860 (Direct) | View |
2022-06-08 Option Award | 2022-06-08 7:48 pm | N/A 2032-06-08 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 34,700 | $0 | 69,860 (Direct) | View |
2022-06-06 Exercise | 2022-06-08 7:48 pm | N/A 2028-05-02 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 6,250 | $0 | 69,860 (Direct) | View |
2021-11-04 Exercise | 2021-11-08 4:22 pm | N/A 2027-05-02 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 10,000 | $0 | 61,456 (Direct) | View |
2021-11-04 Exercise | 2021-11-08 4:22 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 10,000 | $48.15 | 61,456 (Direct) | View |
2021-08-03 Option Award | 2021-08-05 4:33 pm | N/A 2031-07-20 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Medical Officer | 15,000 | $0 | 46,456 (Direct) | View |
2021-06-09 Option Award | 2021-06-11 8:37 pm | N/A 2031-06-09 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 24,500 | $0 | 48,535 (Direct) | View |
2021-03-31 Exercise | 2021-04-02 6:33 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 13,750 | $34.38 | 32,561 (Direct) | View |
2021-03-31 Exercise | 2021-04-02 6:33 pm | N/A 2028-05-02 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 13,750 | $0 | 32,561 (Direct) | View |
2020-06-09 Option Award | 2020-06-11 6:36 pm | N/A 2030-06-09 | Pacira BioSciences Inc. | PCRX | WINSTON ROY Chief Clinical Officer | 49,000 | $0 | 74,237 (Direct) | View |